» Articles » PMID: 33433813

Prevalence and Risk Factors for Osteopathy in Chronic Pancreatitis

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2021 Jan 12
PMID 33433813
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: The high incidence of osteopathy among patients with chronic pancreatitis (CP) has garnered increased attention over recent years. The aims of this study were to assess the prevalence and risk factors for osteopathy in Chinese patients with CP.

Methods: This was a cross-sectional study of CP patients from a large center in China; patients were recruited between 31 January 2017 and 31 January 2018. Bone density and laboratory tests, including bone-related biochemical, inflammatory, and hormone parameters, were assessed prospectively. Differences between patients with and without osteopathy were analyzed. Logistic regression analysis was used to investigate associations between variables.

Results: In total, 104 CP patients were enrolled in this study (68.3% idiopathic and 31.7% alcoholic). According to the M-ANNHEIM classification, 87.5% of the patients were at an early stage (0-II). Osteopenia was diagnosed in 30.8% of patients and osteoporosis in 5.8%; thus, a total of 36.5% of patients presented with osteopathy. In multivariate analysis, the independent risk factors for osteopathy in CP patients were age (OR = 1.04; 95% CI = 1.00-1.08; P = 0.030), BMI (OR = 0.72; 95% CI = 0.58-0.89; P = 0.003), and PTH (OR = 0.96; 95% CI = 0.93-1.00; P = 0.022).

Conclusions: This study is the first to report the prevalence of osteopathy in Chinese patients with CP. It found that age and low BMI are significant risk factors for osteopathy. Low PTH (but within the normal range) showed a weak association with osteopathy, which warrants further exploration.

Citing Articles

Management of chronic pancreatitis: recent advances and future prospects.

Han C, Lv Y, Hu L Therap Adv Gastroenterol. 2024; 17:17562848241234480.

PMID: 38406795 PMC: 10894541. DOI: 10.1177/17562848241234480.


Prevalence of Osteopathy in Chronic Pancreatitis: A Systematic Review and Meta-Analysis.

Ramai D, Facciorusso A, Maida M, Capurso G, Chandan S, Spadaccini M Clin Transl Gastroenterol. 2023; 14(8):e00623.

PMID: 37477620 PMC: 10461948. DOI: 10.14309/ctg.0000000000000623.


Burden of bone disease in chronic pancreatitis: A systematic review and meta-analysis.

Chhoda A, Hernandez-Woodbine M, Addo N, Nasir S, Grimshaw A, Gunderson C World J Gastroenterol. 2023; 29(8):1374-1394.

PMID: 36925454 PMC: 10011962. DOI: 10.3748/wjg.v29.i8.1374.


Vitamin D and Pancreatitis: A Narrative Review of Current Evidence.

Cai F, Hu C, Chen C, Han Y, Lin Z, Deng L Nutrients. 2022; 14(10).

PMID: 35631254 PMC: 9143310. DOI: 10.3390/nu14102113.

References
1.
Sikkens E, Cahen D, Koch A, Braat H, Poley J, Kuipers E . The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology. 2013; 13(3):238-42. DOI: 10.1016/j.pan.2013.02.008. View

2.
Tignor A, Wu B, Whitlock T, Lopez R, Repas K, Banks P . High prevalence of low-trauma fracture in chronic pancreatitis. Am J Gastroenterol. 2010; 105(12):2680-6. DOI: 10.1038/ajg.2010.325. View

3.
Hauk L . Treatment of Low BMD and Osteoporosis to Prevent Fractures: Updated Guideline from the ACP. Am Fam Physician. 2018; 97(5):352-353. View

4.
Barrett-Connor E . The economic and human costs of osteoporotic fracture. Am J Med. 1995; 98(2A):3S-8S. DOI: 10.1016/s0002-9343(05)80037-3. View

5.
Lindkvist B, Dominguez-Munoz J, Luaces-Regueira M, Castineiras-Alvarino M, Nieto-Garcia L, Iglesias-Garcia J . Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis. Pancreatology. 2012; 12(4):305-10. DOI: 10.1016/j.pan.2012.04.006. View